InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Karas Eric. Director active across 1 company, notably ARS Pharmaceuticals, Inc.. Cumulatively, 8 reports have been published. Split: 0 buy · 1 sell. Activity tracked since 19 August 2024. The latest transaction was disclosed on 1 July 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Karas Eric is Chief Commercial Officer at ARS Pharmaceuticals, Inc. He has filed 8 disclosures in total, and across the 8 sampled recent filings, the transactions run from 2024-08-21 to 2026-06-12, with buy volume of EUR 0 and sell volume of EUR 0. The most frequent transaction nature is Option exercise.